StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) bonds

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.65−1.52 (-2.86%)

Close on Nov 17, 2026Market cap $7.18BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$275.56M
$27.36M due within a year
Net debt
$20.29M
After $255.27M of cash
Implied interest rate
23.24%
FY2025 interest ÷ average debt
Interest coverage
-13.4×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Cytokinetics's 10-K for the period ended Dec 31, 2025

IssueMaturesAmount issuedCarrying value
Convertible Senior Notes Due2027
Convertible at $51 a share
Jul 1, 2027$140.53M$147.91M
Convertible Senior Notes Due2031
Convertible at $68 a share
Oct 1, 2031$750.00M$829.15M
RP Ulacamten RPARPIICAV–$150.00M–
Rp Multi Tranche Loan––$499.64M
Rp Om Loan Agreement–$100.00M$227.50M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.

See a number that looks wrong?